In human IBD, the expansion of pathogenic pro-inflammatory CD11chiCCR2+CX3CR1+ macrophages is driven by enhanced CCL2 gradients and contributes to colonic inflammation during IBD [69]. Here, CCL2 is linked to inflammatory bowel disease.